CLINICAL_TRIALS
trial_result
· 2019-05-02
Clinical Trial Update: Study To Assess FRacTure Healing With SclerosTin Antibody - Hip [Phase 2]
Summary
Phase 2 clinical trial evaluating a sclerosTin antibody for fracture healing has completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Fracture Healing | Phase 2 | Status: COMPLETED | Results posted: 2019-05-02